Overview
Ravi Patel is a Hematologist and an Oncologist in Grapevine, Texas. Dr. Patel has been practicing medicine for over 15 years and is rated as an Experienced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Myelodysplastic Syndrome (MDS), Breast Cancer, Mediastinal Tumor, and Merkel Cell Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- POS
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1631 Lancaster Drive, Suite 150, Grapevine, TX 76051
University Of Texas Southwestern Medical Center At Dallas
Hans Hammers is an Oncologist in Dallas, Texas. Dr. Hammers is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Thrombectomy.
Texas Oncology, P.A.
Eric Nadler is an Oncologist in Dallas, Texas. Dr. Nadler has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Pleuropulmonary Blastoma.
University Of Texas Southwestern Medical Center At Dallas
Suzanne Cole is a Hematologist in Richardson, Texas. Dr. Cole is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Thrombectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Patel isAdvanced. Learn about Breast Cancer.
- Iron Deficiency AnemiaDr. Patel isAdvanced. Learn about Iron Deficiency Anemia.
- Mediastinal TumorDr. Patel isAdvanced. Learn about Mediastinal Tumor.
- Merkel Cell CarcinomaDr. Patel isAdvanced. Learn about Merkel Cell Carcinoma.
- Myelodysplastic Syndrome (MDS)Dr. Patel isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Mountain SicknessDr. Patel isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Patel isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Patel isExperienced. Learn about Anal Cancer.
- AnemiaDr. Patel isExperienced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Patel isExperienced. Learn about Childhood Iron Deficiency Anemia.
- Chromophobe Renal Cell CarcinomaDr. Patel isExperienced. Learn about Chromophobe Renal Cell Carcinoma.